SCD and colorectal adenocarcinoma: Moreover, the growth-inhibitory effects induced by pharmacological inhibition of SCD1 in PANC-1 cells [73] and in human colorectal adenocarcinoma LOVO cells (75) were shown to be reduced by OA, in line with the observations in the present study.